121 related articles for article (PubMed ID: 17064911)
21. Palladium-catalyzed hydroacyloxylation of ynamides.
Smith DL; Goundry WR; Lam HW
Chem Commun (Camb); 2012 Feb; 48(10):1505-7. PubMed ID: 21858353
[TBL] [Abstract][Full Text] [Related]
22. Reducing ion channel activity in a series of 4-heterocyclic arylamide FMS inhibitors.
Wilson KJ; Illig CR; Chen J; Wall MJ; Ballentine SK; DesJarlais RL; Chen Y; Schubert C; Donatelli R; Petrounia I; Crysler CS; Molloy CJ; Chaikin MA; Manthey CL; Player MR; Tomczuk BE; Meegalla SK
Bioorg Med Chem Lett; 2010 Jul; 20(13):3925-9. PubMed ID: 20570147
[TBL] [Abstract][Full Text] [Related]
23. N2-substituted O6-cyclohexylmethylguanine derivatives: potent inhibitors of cyclin-dependent kinases 1 and 2.
Hardcastle IR; Arris CE; Bentley J; Boyle FT; Chen Y; Curtin NJ; Endicott JA; Gibson AE; Golding BT; Griffin RJ; Jewsbury P; Menyerol J; Mesguiche V; Newell DR; Noble ME; Pratt DJ; Wang LZ; Whitfield HJ
J Med Chem; 2004 Jul; 47(15):3710-22. PubMed ID: 15239650
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of 3,5-bis(2-indolyl)pyridine and 3-[(2-indolyl)-5-phenyl]pyridine derivatives as CDK inhibitors and cytotoxic agents.
Jacquemard U; Dias N; Lansiaux A; Bailly C; Logé C; Robert JM; Lozach O; Meijer L; Mérour JY; Routier S
Bioorg Med Chem; 2008 May; 16(9):4932-53. PubMed ID: 18439832
[TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of 8-substituted benzamido-phenylxanthine derivatives as MAO-B inhibitors.
Song B; Xiao T; Qi X; Li LN; Qin K; Nian S; Hu GX; Yu Y; Liang G; Ye F
Bioorg Med Chem Lett; 2012 Feb; 22(4):1739-42. PubMed ID: 22257893
[TBL] [Abstract][Full Text] [Related]
26. Two-step total syntheses of canthin-6-one alkaloids: new one-pot sequential Pd-catalyzed Suzuki-Miyaura coupling and Cu-catalyzed amidation reaction.
Gollner A; Koutentis PA
Org Lett; 2010 Mar; 12(6):1352-5. PubMed ID: 20192213
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors.
Chang YT; Gray NS; Rosania GR; Sutherlin DP; Kwon S; Norman TC; Sarohia R; Leost M; Meijer L; Schultz PG
Chem Biol; 1999 Jun; 6(6):361-75. PubMed ID: 10375538
[TBL] [Abstract][Full Text] [Related]
28. Molecular models of cyclin-dependent kinase 1 complexed with inhibitors.
Canduri F; Uchoa HB; de Azevedo WF
Biochem Biophys Res Commun; 2004 Nov; 324(2):661-6. PubMed ID: 15474478
[TBL] [Abstract][Full Text] [Related]
29. Palladium-catalyzed intramolecular 5-exo-dig hydroarylations of N-arylpropiolamides: thermodynamics-controlled stereoselective synthesis of 3-methyleneoxindoles.
Jiang TS; Tang RY; Zhang XG; Li XH; Li JH
J Org Chem; 2009 Nov; 74(22):8834-7. PubMed ID: 19848384
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological activity of olomoucine II.
Krystof V; Lenobel R; Havlícek L; Kuzma M; Strnad M
Bioorg Med Chem Lett; 2002 Nov; 12(22):3283-6. PubMed ID: 12392733
[TBL] [Abstract][Full Text] [Related]
31. 2,6,9-trisubstituted purines: optimization towards highly potent and selective CDK1 inhibitors.
Imbach P; Capraro HG; Furet P; Mett H; Meyer T; Zimmermann J
Bioorg Med Chem Lett; 1999 Jan; 9(1):91-6. PubMed ID: 9990463
[TBL] [Abstract][Full Text] [Related]
32. 2,6,8,9-tetrasubstituted purines as new CDK1 inhibitors.
Moravec J; Krystof V; Hanus J; Havlícek L; Moravcová D; Fuksová K; Kuzma M; Lenobel R; Otyepka M; Strnad M
Bioorg Med Chem Lett; 2003 Sep; 13(18):2993-6. PubMed ID: 12941319
[TBL] [Abstract][Full Text] [Related]
33. A novel series of highly potent 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitors.
Gucký T; Jorda R; Zatloukal M; Bazgier V; Berka K; Řezníčková E; Béres T; Strnad M; Kryštof V
J Med Chem; 2013 Aug; 56(15):6234-47. PubMed ID: 23829517
[TBL] [Abstract][Full Text] [Related]
34. Nitrogen-containing flavonoids as CDK1/Cyclin B inhibitors: design, synthesis, and biological evaluation.
Liu T; Xu Z; He Q; Chen Y; Yang B; Hu Y
Bioorg Med Chem Lett; 2007 Jan; 17(1):278-81. PubMed ID: 17085048
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and structure-activity relationship of 4-(1,3-benzothiazol-2-yl)-thiophene-2-sulfonamides as cyclin-dependent kinase 5 (cdk5)/p25 inhibitors.
Malmström J; Viklund J; Slivo C; Costa A; Maudet M; Sandelin C; Hiller G; Olsson LL; Aagaard A; Geschwindner S; Xue Y; Vasänge M
Bioorg Med Chem Lett; 2012 Sep; 22(18):5919-23. PubMed ID: 22889803
[TBL] [Abstract][Full Text] [Related]
36. Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation.
DiMauro EF; Newcomb J; Nunes JJ; Bemis JE; Boucher C; Chai L; Chaffee SC; Deak HL; Epstein LF; Faust T; Gallant P; Gore A; Gu Y; Henkle B; Hsieh F; Huang X; Kim JL; Lee JH; Martin MW; McGowan DC; Metz D; Mohn D; Morgenstern KA; Oliveira-dos-Santos A; Patel VF; Powers D; Rose PE; Schneider S; Tomlinson SA; Tudor YY; Turci SM; Welcher AA; Zhao H; Zhu L; Zhu X
J Med Chem; 2008 Mar; 51(6):1681-94. PubMed ID: 18321037
[TBL] [Abstract][Full Text] [Related]
37. Discovery of novel purine derivatives with potent and selective inhibitory activity against c-Src tyrosine kinase.
Huang H; Ma J; Shi J; Meng L; Jiang H; Ding J; Liu H
Bioorg Med Chem; 2010 Jul; 18(13):4615-24. PubMed ID: 20570525
[TBL] [Abstract][Full Text] [Related]
38. Palladium-catalyzed direct arylation of azine and azole N-oxides: reaction development, scope and applications in synthesis.
Campeau LC; Stuart DR; Leclerc JP; Bertrand-Laperle M; Villemure E; Sun HY; Lasserre S; Guimond N; Lecavallier M; Fagnou K
J Am Chem Soc; 2009 Mar; 131(9):3291-306. PubMed ID: 19215128
[TBL] [Abstract][Full Text] [Related]
39. A convenient synthesis and molecular modeling study of novel purine and pyrimidine derivatives as CDK2/cyclin A3 inhibitors.
Elgazwy AS; Ismail NS; Elzahabi HS
Bioorg Med Chem; 2010 Nov; 18(21):7639-50. PubMed ID: 20851615
[TBL] [Abstract][Full Text] [Related]
40. Derailing the Wacker oxidation: development of a palladium-catalyzed amidation reaction.
Gaunt MJ; Spencer JB
Org Lett; 2001 Jan; 3(1):25-8. PubMed ID: 11429862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
